New boost to Cure Leukaemia appeal

Birmingham tech company to support expansion fund.

Enterprise mobility and IT specialist Intercity Technology will be supporting Cure Leukaemia as an official charity partner throughout 2017.

The Birmingham-headquartered business, which has offices across the UK and Europe, will be raising funds throughout the year towards Cure Leukaemia’s £1 million appeal to fund the expansion of the Centre for Clinical Haematology at the Queen Elizabeth Hospital in Birmingham.

The £3.2 million expansion to double the capacity of the world class centre, which is leading the global fight against all forms of blood cancer, began in late May and is expected to reopen to treat patients in November. Over £2 million has been granted by the Local Growth Fund and blood cancer charity Cure Leukaemia has made a commitment to raising and additional £1 million in 2017 to ensure the project is fully funded.

Once established, the Centre’s capacity for research nurse positions, clinical trials and patients treated will be doubled and these are just some of the benefits that development will enable. Not only will the Centre immediately increase the number of lives saved but also hasten global progress towards establishing effective treatments for all blood cancers within 25 years.

All funds raised for Cure Leukaemia through major events such as Velo Birmingham, Glynn Purnell’s Friday Night Kitchen, the Birmingham International Marathon and Simplyhealth Great Birmingham Run to name a few will go towards the £1m appeal. Fundraising from the charity’s corporate partners, such as Intercity Technology, and community supporters will also help Cure Leukaemia reach the inspirational goal by the deadline of December 31st this year.

Andrew Jackson, CEO at Intercity Technology (pictured above) said: “We are passionate about helping to raise funds for Cure Leukaemia in such a vital and transformative year for the charity. Knowing that our fundraising efforts will not only directly help to save lives, but also hasten global progress towards eradicating the disease, will be a great inspiration to all our colleagues. We are looking forward to discussing fundraising ideas with Cure Leukaemia in the coming weeks.”

Cure Leukaemia’s Head of Corporate Partnerships Jackie Kelly added: “It is fantastic to have another major business in Birmingham supporting Cure Leukaemia, especially in such a vital and transformational year. We look forward to working with a company that has energy and enthusiasm which, I am sure, will translate into their fundraising efforts.”